Logo image of AAQ1.DE

AAP IMPLANTATE (AAQ1.DE) Stock Price, Forecast & Analysis

Europe - Frankfurt Stock Exchange - FRA:AAQ1 - DE000A3H2101 - Common Stock

1.52 EUR
0 (0%)
Last: 1/26/2026, 7:00:00 PM

AAQ1.DE Key Statistics, Chart & Performance

Key Statistics
Market Cap21.14M
Revenue(TTM)12.20M
Net Income(TTM)-3.63M
Shares13.91M
Float5.33M
52 Week High2
52 Week Low1.08
Yearly DividendN/A
Dividend Yield0%
EPS(TTM)-0.35
PEN/A
Fwd PEN/A
Earnings (Next)06-18
IPO1999-05-10
Sector
GICS SectorHealth Care
GICS IndustryHealth Care Equipment & Supplies
GICS IndustryGroupHealth Care Equipment & Services
GICS SubIndustryHealth Care Equipment
AAQ1.DE short term performance overview.The bars show the price performance of AAQ1.DE in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 10 -10 -20

AAQ1.DE long term performance overview.The bars show the price performance of AAQ1.DE in the last 1, 2 and 3 years. 1 year 2 years 3 years 0 20 40 60 80

The current stock price of AAQ1.DE is 1.52 EUR. In the past month the price increased by 13.43%. In the past year, price decreased by -1.94%.

AAP IMPLANTATE / AAQ1 Daily stock chart

AAQ1.DE Technical Analysis

ChartMill assigns a technical rating of 5 / 10 to AAQ1.DE. When comparing the yearly performance of all stocks, AAQ1.DE turns out to be only a medium performer in the overall market: it outperformed 44.28% of all stocks.


Chartmill TA Rating
Chartmill Setup Rating

AAQ1.DE Fundamental Analysis

ChartMill assigns a fundamental rating of 2 / 10 to AAQ1.DE. The financial health of AAQ1.DE is average, but there are quite some concerns on its profitability.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

AAQ1.DE Financial Highlights

Over the last trailing twelve months AAQ1.DE reported a non-GAAP Earnings per Share(EPS) of -0.35. The EPS increased by 63.21% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -25.96%
ROE -38.7%
Debt/Equity 0.03
Chartmill High Growth Momentum
EPS Q2Q%21.53%
Sales Q2Q%-3.32%
EPS 1Y (TTM)63.21%
Revenue 1Y (TTM)6.32%

AAQ1.DE Forecast & Estimates

For the next year, analysts expect an EPS growth of 65% and a revenue growth 15.38% for AAQ1.DE


Analysts
Analysts42.22
Price TargetN/A
EPS Next Y65%
Revenue Next Year15.38%

AAQ1.DE Ownership

Ownership
Inst Owners22.99%
Ins Owners10.14%
Short Float %N/A
Short RatioN/A

About AAQ1.DE

Company Profile

AAQ1 logo image aap Implantate AG is a medical device company, which engages in the development, manufacture, and market of trauma products for orthopedics. The company is headquartered in Berlin, Berlin and currently employs 90 full-time employees. The firm focuses on trauma and biomaterials products for orthopedics. The Biomaterials portfolio comprises bone substitutes for the filling of aseptic bone defects, bone cements and accessories for the application in arthroplasty, bone cements and accessories for the application in vertebroplasty and kyphoplasty. The trauma portfolio includes a wide range of cannulated screws, standard plates and screws for miniature, small and large bone fragments, among others . The company also develops LOQTEQ, a technology that allows for fracture compression with subsequent locking fixation in one surgical step. The firm operates a network of distributors in more than 60 countries, and cooperates directly with physicians and hospital customers.

Company Info

AAP IMPLANTATE

Lorenzweg 5

Berlin BERLIN DE

Employees: 87

AAQ1 Company Website

AAQ1 Investor Relations

Phone: 4930750190

AAP IMPLANTATE / AAQ1.DE FAQ

What does AAQ1 do?

aap Implantate AG is a medical device company, which engages in the development, manufacture, and market of trauma products for orthopedics. The company is headquartered in Berlin, Berlin and currently employs 90 full-time employees. The firm focuses on trauma and biomaterials products for orthopedics. The Biomaterials portfolio comprises bone substitutes for the filling of aseptic bone defects, bone cements and accessories for the application in arthroplasty, bone cements and accessories for the application in vertebroplasty and kyphoplasty. The trauma portfolio includes a wide range of cannulated screws, standard plates and screws for miniature, small and large bone fragments, among others . The company also develops LOQTEQ, a technology that allows for fracture compression with subsequent locking fixation in one surgical step. The firm operates a network of distributors in more than 60 countries, and cooperates directly with physicians and hospital customers.


Can you provide the latest stock price for AAP IMPLANTATE?

The current stock price of AAQ1.DE is 1.52 EUR.


Does AAQ1 stock pay dividends?

AAQ1.DE does not pay a dividend.


What is the ChartMill technical and fundamental rating of AAQ1 stock?

AAQ1.DE has a ChartMill Technical rating of 5 out of 10 and a ChartMill Fundamental rating of 2 out of 10.


What is the GICS sector and industry of AAQ1 stock?

AAP IMPLANTATE (AAQ1.DE) operates in the Health Care sector and the Health Care Equipment & Supplies industry.


What is the expected growth for AAQ1 stock?

The Revenue of AAP IMPLANTATE (AAQ1.DE) is expected to grow by 15.38% in the next year. Check the estimates tab for more information on the EPS, Sales, EBIT and EBITDA future analyst estimates.


Can you provide the ownership details for AAQ1 stock?

You can find the ownership structure of AAP IMPLANTATE (AAQ1.DE) on the Ownership tab.